Literature DB >> 10450055

Effects of active immunization with a pneumococcal surface protein (PspA) and of locally applied antibodies in experimental otitis media.

P White1, A Hermansson, C Svanborg, D Briles, K Prellner.   

Abstract

An experimental rat model for Streptococcus pneumoniae otitis media was used to investigate passive protection by anti-type 3 capsular antibodies and effects of immunization with pneumococcal surface protein A (PspA). Anti-type 3 antibodies instilled into the middle ear reduced purulent otitis media as compared to control animals (p = 0.015). Secondly, after immunization with PspA, the right middle ear was inoculated with S. pneumoniae type 6A in a dose calibrated to induce purulent otitis media. There was an anti-PspA antibody response in all rats immunized and a reduction in signs of purulent otitis media as compared to control animals (p = 0.026). Thus, purulent (acute) otitis media can be reduced by local application of antibodies in the middle ear and also by immunization with a non-type-specific pneumococcal protein, PspA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450055     DOI: 10.1159/000027672

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  9 in total

Review 1.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 2.  Prevention of otitis media by vaccination.

Authors:  Fiona Russell; Kim Mulholland
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae.

Authors:  Merit M Melin; Susan K Hollingshead; David E Briles; Mika I Lahdenkari; Terhi M Kilpi; Helena M Käyhty
Journal:  Clin Vaccine Immunol       Date:  2008-08-27

4.  Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers.

Authors:  Merit M Melin; Susan K Hollingshead; David E Briles; William P Hanage; Mika Lahdenkari; Tarja Kaijalainen; Terhi M Kilpi; Helena M Käyhty
Journal:  Clin Vaccine Immunol       Date:  2008-08-27

5.  Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children.

Authors:  M C Vela Coral; N Fonseca; E Castañeda; J L Di Fabio; S K Hollingshead; D E Briles
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

6.  Genetic diversity of pneumococcal surface protein A in invasive pneumococcal isolates from Korean children, 1991-2016.

Authors:  Ki Wook Yun; Eun Hwa Choi; Hoan Jong Lee
Journal:  PLoS One       Date:  2017-11-13       Impact factor: 3.240

7.  Vaccine prevention of acute otitis media.

Authors:  D P Greenberg; A Hoberman
Journal:  Curr Allergy Asthma Rep       Date:  2001-07       Impact factor: 4.806

8.  IgG responses to Pneumococcal and Haemophilus influenzae protein antigens are not impaired in children with a history of recurrent acute otitis media.

Authors:  Selma P Wiertsema; Karli J Corscadden; Eva N Mowe; Guicheng Zhang; Shyan Vijayasekaran; Harvey L Coates; Timothy J Mitchell; Wayne R Thomas; Peter C Richmond; Lea-Ann S Kirkham
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

9.  The Modified Surface Killing Assay Distinguishes between Protective and Nonprotective Antibodies to PspA.

Authors:  Kristopher R Genschmer; Cintia F M Vadesilho; Larry S McDaniel; Sang-Sang Park; Yvette Hale; Eliane N Miyaji; David E Briles
Journal:  mSphere       Date:  2019-12-11       Impact factor: 4.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.